Clinical outcomes and safety of remdesivir in hospitalized individuals with COVID-19, with or without severe renal impairment

Background: The use of remdesivir in patients with coronavirus disease 2019 (COVID-19) and severe renal impairment has been approved; however, limited clinical data exist. Accordingly, we aimed to compare outcomes and adverse events associated with remdesivir in hospitalized patients with COVID-19,...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Min-Chi Chang, Ping-Feng Wu, Yu-Chien Ho, Wen-Ying Lin, Chia-Ying Wu, Szu-Yu Liu, Chia-Jen Liu, Yi-Tsung Lin
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Elsevier 2024-07-01
Schriftenreihe:	Journal of Infection and Public Health
Schlagworte:	Remdesivir COVID-19 Clinical outcomes Severe renal impairment
Online-Zugang:	http://www.sciencedirect.com/science/article/pii/S1876034124001874
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!